Apprentice.io, the creator of an AI-powered manufacturing platform for life sciences, has partnered with Aprecia, a leader in pharmaceutical three-dimensional printing (3DP) to combine AI technology with 3DP innovation in drug delivery.

Through this partnership, Aprecia will implement Apprentice.io’s intelligent manufacturing platform at its Ohio facility to accelerate production workflows designed to ensure consistent, reliable execution at scale. The integration will support Aprecia’s mission to revolutionize how medications are produced and delivered using advanced additive manufacturing.

Apprentice’s cloud-native platform delivers intuitive digital manufacturing capabilities and no-code integration tools that provide flexibility, scalability, and connectivity appropriate for Aprecia’s manufacturing model. As Aprecia continues to grow, this technology foundation will enable rapid deployment and seamless scaling across multiple production sites.

“I believe that Aprecia is the next generation of additive manufacturing,” said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. “They are at the absolute forefront of innovation in life sciences, combined with our AI native approach to manufacturing, I am looking forward to seeing what we can accomplish in the future.”

Aprecia’s deployment of Apprentice’s technology reflects a shared commitment for next level pharmaceutical manufacturing. The collaboration underscores the industry’s rapid evolution toward more sophisticated, data-driven manufacturing approaches that can adapt to and scale complex formulation requirements while maintaining the highest quality standards.

“Aprecia is leading the way in pharmaceutical 3D printing, driven by a commitment to transform patient care through innovation,” said Kyle Smith, President and COO at Aprecia. “Our partnership with Apprentice.io strengthens that mission, leveraging AI-powered solutions to scale precision drug delivery and redefine what’s possible in oral medication.”